ADRB2 and myalgic encephalomeyelitis/chronic fatigue syndrome: The ß2-adrenergic receptor antibody (ADRB2 AAB) was the best discriminator of PCS, and both fatigue and vasomotor symptoms were strongly associated with the levels of ADRB2 AABs in PCS-ME/CFS patients [13].